Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:929 (22 April), doi:10.1136/bmj.332.7547.929
David Brown
Baltimore
| The first 150 words of the full text of this article appear below. |
The value of the name of Johns Hopkins, the 19th century Quaker philanthropist who endowed one of the great medical institutions of the United States, is at the centre of a public debate that is forcing US academic medicine to think hard about what happens when science meets branding.
In late February a New York cosmetics company, Klinger Advanced Aesthetics, announced the release of a line of products called "Cosmedicine." The 15 skin products, whose prices range from $28 (£16;
23) to $85, included hydrators, exfoliators, pore shrinkers, sun blockers, and shine suppressors.
The marketing pitch of the new products was that their biological performance was scientifically verified, unlike that of nearly all their competitors. The data appearing on Cosmedicine labels attesting to skin change after application of the creams and "serums" aren't the opinion of users; instead they are the results of tests performed by contract laboratories and overseen
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?